masstort.news
Mass tort & MDL intelligence · for attorneys
Live
For informational purposes only — not legal advice. All case data sourced from public court records, PACER, JPML, and cited news outlets. Verify all information independently.
   ⚖ 3M Combat Arms $6B settlement distributing — MDL 2885 (N.D. Fla.)    ·    J&J Talc: $8.9B plan under 3rd Cir. review — LTL Management Ch. 11    ·    AFFF/PFAS MDL 2873: personal injury bellwether track confirmed by Judge Gergel    ·    GLP-1 / Ozempic gastroparesis: JPML consolidation petition pending    ·    Social Media MDL 3047: bellwether pool selection underway — N.D. Cal.    ·    Camp Lejeune PACT Act: 200,000+ claims filed — E.D.N.C. trial track advancing    ·    Hair Relaxer MDL 3060: pre-trial motions stage — N.D. Ill.    ·    Purdue Pharma SCOTUS ruling reshapes mass tort bankruptcy strategy    ·    Depo-Provera meningioma claims: MDL petition anticipated — Pfizer named    ·    Suboxone MDL 3092: bellwether selection underway — N.D. Ohio       
Today's intelligence briefing
Settlement Apr 2025

3M Combat Earplugs: $6B settlement fund begins Tier 1 distributions to veterans

Over 240,000 veterans in MDL No. 2885 (N.D. Fla., Judge Casey Rodgers) alleged bilateral hearing loss from defective Combat Arms Earplugs Version 2. Claims administrator Epiq is now processing Tier 1 payments. J&J's Texas Two-Step subsidiary Aearo Technologies' separate bankruptcy was dismissed — all claims proceed in MDL.

Source: Reuters · MDL No. 2885
MDL: No. 2885, N.D. Fla. — largest MDL by claimant count in U.S. history
Defect: Dual-ended design failed to attenuate impulse noise; Aearo knew of flaw pre-sale to military
Structure: Base & Enhanced Tiers based on injury severity; opt-outs pursuing individual trial tracks
Bankruptcy: 7th Cir. dismissed Aearo Ch. 11 — automatic stay denied; MDL proceedings resumed
Watch: Remaining bellwether opt-out trials ongoing — verdicts have ranged from defense wins to $77M plaintiff awards
Judge's Order Apr 2025

AFFF/PFAS MDL: Judge Gergel confirms bellwether schedule for personal injury cancer track

MDL 2:18-mn-2873 (D.S.C.) — 3M's $10.3B and DuPont's $1.185B municipal water settlements approved. Personal injury cancer claims (kidney, testicular, bladder, thyroid cancer) now advancing to trial. Defendants include 3M, DuPont, Chemours, and Corteva.

Source: Law360 · MDL 2:18-mn-2873
Track 1: Municipal water systems — resolved via 3M ($10.3B) and DuPont ($1.185B) settlements
Track 2: Personal injury cancer — kidney, testicular, bladder, thyroid cancers alleged from PFAS exposure
Science: PFAS classified "likely carcinogenic" by EPA; IARC Group 1 (carcinogenic) for PFOA confirmed 2023
Daubert: Causation expert challenges — key to whether PI cases survive to trial
Watch: PI bellwether selection, daubert motions on causation, and first cancer trial date
MDL Apr 2025

J&J Talc: Third Circuit to hear appeal of "Texas Two-Step" bankruptcy plan

J&J's third bankruptcy attempt (LTL Management 3.0) proposes $8.9B settlement requiring 75% claimant acceptance. Prior petitions dismissed by 3rd Cir. in 2023 and 2024 for lack of financial distress. SCOTUS's 2024 Purdue Pharma ruling limiting non-debtor releases directly threatens J&J's strategy.

Source: Bloomberg Law · In re: LTL Management LLC
Strategy: NC divisional merger spun talc liabilities into LTL Management → Ch. 11 filed to resolve all claims
History: LTL 1.0 dismissed Jan 2023; LTL 2.0 dismissed Jul 2024; LTL 3.0 now pending 3rd Cir.
SCOTUS: Purdue Pharma ruling (Jun 2024) limits non-debtor releases — directly impacts J&J strategy
Opposition: Major plaintiff firms and claimant committee allege $8.9B undervalues claims; plan is coercive
Watch: Whether 3rd Cir. applies Purdue to reject plan confirmation; potential SCOTUS cert petition
Emerging Mar 2025

Social Media Addiction MDL 3047: §230 design defect claims survive — bellwether pool selection underway

Judge Yvonne Gonzalez Rogers (N.D. Cal.) denied defendants' §230 immunity motion on design defect claims. Meta, TikTok, Snap, and YouTube face allegations their recommendation algorithms caused addiction, depression, self-harm, and eating disorders in minors. School district economic harm claims also active.

Source: Courthouse News · MDL 3047
Theory: Product liability — defective algorithm design targeting minors; failure to warn of addiction risk
§230: Design defect claims survive — court distinguishes editorial function from product design decisions
Plaintiffs: Minors alleging depression, anxiety, self-harm, eating disorders, suicide attempts; school districts
Discovery: Internal documents from Meta and TikTok showing awareness of youth harm are central
Watch: Bellwether trials expected 2025–2026 — expert causation testimony will be decisive
Verdict Mar 2025

Roundup/Glyphosate: California appellate courts sustain Monsanto liability; state court cases continue

Despite Bayer's $10.9B settlement (largely distributed), thousands of opt-out cases remain active in state courts. California appellate courts have consistently upheld jury verdicts finding Roundup caused non-Hodgkin lymphoma, rejecting federal preemption. SCOTUS denied cert in Hardeman (2022).

Source: Reuters · Hardeman v. Monsanto, 997 F.3d 941 (9th Cir. 2021)
Key case: Hardeman v. Monsanto — 9th Cir. affirmed; SCOTUS denied cert May 2022
Settlement: Bayer's $10.9B fund (2020) settled ~100,000 claims; significant opt-out pool litigating
Preemption: FIFRA does not preempt state failure-to-warn claims — federal preemption defense rejected
Science: IARC 2A classification (probable carcinogen) vs. EPA "not likely" — central jury dispute
Active: Missouri, California state courts; new filing activity continuing in 2024–2025
Active Federal MDL Docket — JPML
Data sourced from JPML public records, PACER, and judicial orders. Claimant counts are approximate as of Q1 2025. Always verify current docket status independently.
Litigation MDL No. Court Judge Claims Status
Social Media Addiction (Youth)3047N.D. Cal.Gonzalez Rogers14,000+Active
AFFF / PFAS Contamination2:18-mn-2873D.S.C.Gergel7,000+Bellwether
Camp Lejeune WaterPACT ActE.D.N.C.Dever200,000+Active
3M Combat Earplugs2885N.D. Fla.Rodgers240,000Settling
Paraquat Parkinson's3004S.D. Ill.Rosenstengel5,800+Pre-trial
Hair Relaxer / Uterine Cancer3060N.D. Ill.Ellis8,000+Active
NEC Baby Formula3026N.D. Ill.Shah3,000+Trial track
Acetaminophen / Autism-ADHD3043S.D.N.Y.Cote600+Active
Exactech Orthopedic Implants3044E.D.N.Y.Kovner3,600+Active
Suboxone Tooth Decay3092N.D. OhioLioi2,400+Pre-trial
CPAP / Philips Respironics3014W.D. Pa.Conti80,000+Active
Zantac / Ranitidine2924S.D. Fla.Ruiz80,000+Expert excl.
Watch List — Emerging & Pre-MDL Litigation
Emerging2025

GLP-1 drugs (Ozempic / Wegovy / Mounjaro) — gastroparesis & intestinal obstruction

MDL consolidation petition filed. Novo Nordisk and Eli Lilly named. Strongest cases involve patients who developed permanent gastric paralysis requiring surgery. JPML decision pending. Cases active in E.D. Pa., S.D.N.Y., and C.D. Cal. Defendants claim labeling adequately disclosed GI risks.

Source: Bloomberg Law, PACER
Emerging2025

Depo-Provera / medroxyprogesterone — intracranial meningioma claims against Pfizer

Based on landmark 2024 French pharmacovigilance study showing 5.6x elevated meningioma risk with long-term injectable contraceptive use. Early filings in E.D. Mo. and N.D. Cal. MDL consolidation anticipated. Strongest cases involve prolonged use (>5 years) and cranial surgery.

Watch2025

CPAP / Philips Respironics foam degradation — MDL 3014 cancer injury bellwethers advancing

MDL 3014 (W.D. Pa., Judge Conti) — Philips recalled ~15M CPAP/BiPAP devices due to polyester-based polyurethane foam degradation releasing carcinogenic volatile compounds. Economic loss subclass settled. Cancer injury subclass bellwether trials being prepared; causation discovery ongoing.

Source: Law360 · MDL 3014
Watch2025

Suboxone tooth decay MDL 3092 — buprenorphine/naloxone film causes severe dental injury

MDL 3092 (N.D. Ohio, Judge Lioi) — Indivior faces claims that sublingual film caused severe tooth decay, fractures, and tooth loss. Manufacturer allegedly knew of risk and withheld from FDA and prescribers until 2022 label update. Bellwether selection underway.

Source: Reuters · MDL 3092
Watch2024–2025

NEC Baby Formula MDL 3026 — plaintiff jury verdicts in Illinois courts; trials continuing

Mead Johnson (Enfamil) and Abbott (Similac) face claims that cow's milk-based premature infant formula causes necrotizing enterocolitis (NEC) in premature neonates. Multiple significant plaintiff verdicts in Illinois state courts. Federal MDL 3026 (N.D. Ill., Judge Shah) advancing on parallel track.

Source: Law360 · MDL 3026
Settlement Tracker — Major Mass Tort Resolutions
CaseAmountYearStatus
Opioids — J&J + Big 3 distributors$26B2022Paying
AFFF/PFAS — 3M (municipal water)$10.3B2023Approved
PG&E Camp Fire wildfire$13.5B2020Complete
Roundup / Bayer-Monsanto$10.9B2020Largely paid
J&J Talc — LTL 3.0 proposed$8.9BPendingUnder appeal
3M Combat Earplugs$6.01B2023Distributing
Purdue Pharma / opioids$6B+2022Distributing
AFFF/PFAS — DuPont entities$1.185B2023Approved
Opioids — McKinsey & Co.$900M2021Complete
Opioids — Walmart, CVS, Walgreens$13.8B2022Paying
Boy Scouts of America abuse$2.46B2023Distributing
3M PFAS — State AG claims (additional)$450M+2023Paying
AI-Powered Case Research

One-click AI briefings on any MDL, judge's order, or emerging tort. All results are web-searched and source-cited in real time.

Custom research query